Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Phreesia, Inc. (PHR : NYSE)

• Company Description    Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. Number of Employees: 1,789

• Price / Volume Information    Yesterday's Closing Price: $10.00 Daily Weekly Monthly 20 Day Moving Average: 720,837 shares Shares Outstanding: 62.07 (millions) Market Capitalization: $620.71 (millions) Beta: 0.86 52 Week High: $24.25 52 Week Low: $7.77 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.68% -15.39% 12 Week -8.59% -11.21% Year To Date -40.90% -47.49%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1521 Concord Pike Suite 301 PMB 221 - Wilmington,DE 19803 USA ph: 888-654-7473 fax: 646-607-1776 investors@phreesia.com http://www.phreesia.com

• General Corporate Information    Officers Chaim Indig - Chief Executive Officer Michael Weintraub - Chairman Balaji Gandhi - Chief Financial Officer Yvonne Hui - SVP; Principal Accounting Officer Edward Cahill - Director Peer Information Phreesia, Inc. (HLIS) Phreesia, Inc. (AZTA) Phreesia, Inc. (APYI) Phreesia, Inc. (RNVA) Phreesia, Inc. (HMSY) Phreesia, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 71944F106 SIC: 7389 Fiscal Year Fiscal Year End: January Last Reported Quarter: 07/01/26 Next Expected EPS Date: 12/14/26 Share - Related Items Shares Outstanding: 62.07 Most Recent Split Date: (:1) Beta: 0.86 Market Capitalization: $620.71 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.13 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.33 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 12/14/26

• Fundamental Ratios P/E Current FY Estimate: 30.08 Trailing 12 Months: 33.33 PEG Ratio: - Price Ratios Price/Book: 1.67 Price/Cash Flow: 13.40 Price / Sales: 1.22 EPS Growth vs. Year Ago Period: 200.00% vs. Previous Quarter: -40.00% Sales Growth vs. Year Ago Period: 10.41% vs. Previous Quarter: -1.13% ROE 07/31/26 - 5.22 04/30/26 - 5.13 01/31/26 - 3.23 ROA 07/31/26 - 3.02 04/30/26 - 3.12 01/31/26 - 2.11 Current Ratio 07/31/26 - 1.76 04/30/26 - 1.76 01/31/26 - 1.53 Quick Ratio 07/31/26 - 1.76 04/30/26 - 1.76 01/31/26 - 1.53 Operating Margin 07/31/26 - 3.57 04/30/26 - 3.40 01/31/26 - 2.08 Net Margin 07/31/26 - 2.06 04/30/26 - 1.85 01/31/26 - 0.48 Pre-Tax Margin 07/31/26 - 0.54 04/30/26 - -0.21 01/31/26 - -1.86 Book Value 07/31/26 - 5.99 04/30/26 - 5.81 01/31/26 - 5.59 Inventory Turnover 07/31/26 - - 04/30/26 - - 01/31/26 - - Debt-to-Equity 07/31/26 - 0.33 04/30/26 - 0.41 01/31/26 - 0.41 Debt-to-Capital 07/31/26 - 24.54 04/30/26 - 28.92 01/31/26 - 28.96

Powered by Zacks Investment Research ©